Using human cells, targeting PI5P4Kα/β inhibits mTORC1 phospho-target expression and exposes metabolic vulnerability to sarcoma and breast cancer cell survival under conditions of nutrient stress (9, 54). Here, PIP4K2A is linked to sarcoma.